This is research study examines the safety and effectiveness of an investigational medication for psoriasis. Study participants must be 18 to 75 years of age and have moderate to severe plaque-type psoriasis.
The total time commitment for this study is up to 5 years and will involve up to 49 visits to the study centre. Compensation is available for time and travel associated with the study.
The study is being conducted by Dermatologists who specialize in the assessment of psoriasis. If you are interested please contact our clinical trials manager, Olga Halperin at (416) 633-0001 (ext. 4) today!